Biotech

New Analysis Shows Lower Mortality Rates and Less Need for Redosing When Treating Neonatal Respiratory Distress Syndrome With CUROSURF(R) vs. Survanta(R)

CARY, NC: Independent Systematic Review and Meta-Analysis Compares Efficacy of Respiratory Distress Syndrome Treatments in Preterm Infants ...

Theratechnologies to Announce Results for Its 2011 Fiscal Year

MONTREAL, QUEBEC: ...

BioPharm Asia Acquires Specialty Hospital in Fujian

NEW YORK, NY and TONGHUA, CHINA: ...

Pacgen Closes Private Placement Financing

VANCOUVER, BRITISH COLUMBIA: ...

OctoPlus Announces the Proposal to Appoint Staf Van Reet to the Supervisory Board

LEIDEN, NETHERLANDS: ...

Critical Outcome Technologies Inc. Initiates Preclinical Testing of AML Drug Candidates

LONDON, ONTARIO: ...

Concerned Shareholders of Helix BioPharma Corp. Announce Level of Support from Shareholders, Look Forward to the January 30, 2012 Shareholder Meeting and Respond to Desperate Move by Incumbents

TORONTO, ONTARIO: ...

NCPDP Announces Its 2011 Year in Review

SCOTTSDALE, AZ: ...

The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With App Pharmaceuticals

PARSIPPANY, NJ: ...

Marina Biotech Receives Notice of Acceptance for Patent Broadly Covering Its Unlocked Nucleobase Analog (UNA) Technology

BOTHELL, WA: Patent Protects Use of UNAs in Multiple Nucleic Acid Constructs Including siRNAs, microRNA Mimics, Antagomirs and Single-Stranded Constructs ...